The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study. [electronic resource]
Producer: 20150724Description: 590-5 p. digitalISSN:- 1525-6006
- Adrenergic alpha-Antagonists -- administration & dosage
- Adrenergic beta-Antagonists -- administration & dosage
- Aged
- Aged, 80 and over
- Amlodipine -- administration & dosage
- Antihypertensive Agents -- administration & dosage
- Asian People
- Blood Pressure -- drug effects
- Calcium Channel Blockers -- administration & dosage
- China
- Circadian Rhythm
- Drug Therapy, Combination
- Essential Hypertension
- Felodipine -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Hypertension -- drug therapy
- Male
- Middle Aged
- Nifedipine -- administration & dosage
- Propanolamines -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.